DIABETES MELLITUS AS A SIDE EFFECT OF TREATMENT WITH TRICYCLIC NEUROLEPTICS.
D014150:Antipsychotic Agents; D002746:Chlorpromazine / Q000633:toxicity*; D003006:Clopenthixol; D003920:Diabetes Mellitus; D004358:Drug Therapy; D005951:Glucose Tolerance Test; D006801:Humans; D010546:Perphenazine; D013223:Statistics as Topic; D013881:Thioridazine; D014116:Toxicology; D014149:Tranquilizing Agents
D014150:Antipsychotic Agents; D014149:Tranquilizing Agents; D003006:Clopenthixol; D010546:Perphenazine; D013881:Thioridazine; D002746:Chlorpromazine
CHLORPROMAZINE TOXICOLOGY; CLOPENTHIXOL; DIABETES MELLITUS; DRUG THERAPY; GLUCOSE TOLERANCE TEST; PERPHENAZINE; STATISTICS; THIORIDAZINE; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS